A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2006
11/22/2006	CN1864721A Chinese medicinal wine
11/22/2006	CN1864685A Application of tetrodotoxin as analgesic tolerance inhibitor in preparation of compound pain relieving preparation
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285360C Medicine compound having synergistic action
11/22/2006	CN1285336C Colon-released preparation of Melocicon and beta-cyclodextrin or its derivative composition
11/22/2006	CN1285333C Colon target releasing oral preparation and its preparing method
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138426 Estrogen receptor modulators
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138395 Interleukin-1β converting enzyme inhibitors
11/21/2006	US7138394 Vehicle for topical delivery of anti-inflammatory compounds
11/21/2006	US7138386 Preventives or remedies for arthritis
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/18/2006	CA2547251A1 Fused pyrazolyl compounds for cancer treatment
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006122250A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
11/16/2006	WO2006122242A2 Compositions and methods for the treatment of inflammatory bowel disease utilizing nf-kb decoy polynucleotides
11/16/2006	WO2006122200A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	WO2006122156A2 Compounds for modulating trpv3 function
11/16/2006	WO2006122154A2 Pyridone derivatives for modulating stress-activated protein kinase system
11/16/2006	WO2006121391A1 New compounds i
11/16/2006	WO2006121390A2 Benzoic acid derivatives that are modulators or agonists of glyr
11/16/2006	WO2006121104A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	WO2006121097A1 Bicyclic heterocyclic derivative or salt thereof
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	WO2006120974A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
11/16/2006	WO2006120696A2 An improved pharmaceutical composition
11/16/2006	WO2006120544A1 β-AMINO ACID DERIVATIVES
11/16/2006	WO2006120481A2 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
11/16/2006	WO2006120010A2 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
11/16/2006	WO2006107957A3 Device and methods for treating paranasal sinus conditions
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258742 Hydroxy tetrahydro-naphthalenylurea derivatives
11/16/2006	US20060258730 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258690 Spiro-substituted pyrrologyrimidines
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258601 Formulation for inwardly transferring nucleic acids into eucaryotic cells
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257329 Delivery of drug esters through an inhalation route
11/16/2006	DE102005021806A1 Verwendung von radikalfangenden Substanzen zur Behandlung von Zuständen mit erhöhter Hauttemperatur, insbesondere zur antipyretischen Behandlung Use of free radical scavenging substances for the treatment of conditions with increased skin temperature, especially for antipyretic treatment
11/16/2006	CA2608889A1 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
11/16/2006	CA2608194A1 Compounds for modulating trpv3 function
11/16/2006	CA2608116A1 Method of modulating stress-activated protein kinase system
11/16/2006	CA2608091A1 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
11/16/2006	CA2608024A1 Use of flibanserin in the treatment of chronic pain
11/16/2006	CA2607938A1 Benzoic acid derivatives that are modulators or agonists of glyr
11/16/2006	CA2607933A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
11/16/2006	CA2607929A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	CA2607639A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	CA2607267A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
11/16/2006	CA2606254A1 .beta.-amino acid derivatives
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1720893A2 Compositions and methods for the systemic treatment of arthritis
11/15/2006	EP1720889A1 Sulfated oligosaccharide derivatives
11/15/2006	EP1720871A1 3,5-disubstituted 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors
11/15/2006	EP1720868A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/15/2006	EP1720864A1 Benzimidazol substituted thiophene derivatives with activity on ikk3
11/15/2006	EP1720860A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720845A1 Isothiourea derivatives
11/15/2006	EP1720844A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
11/15/2006	EP1720835A1 Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors
11/15/2006	EP1720826A2 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
11/15/2006	EP1720572A1 Monovalent ligand of the fcalphari receptor as an anti-inflammatory agent
11/15/2006	EP1720561A1 Botanical extract composition
11/15/2006	EP1720552A2 Methods for treating inflammatory and autoimmune diseases
11/15/2006	EP1720551A1 Alkaloid formulations
11/15/2006	EP1670778B1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
11/15/2006	EP1646387B1 Use of indazole derivatives for the treatment of neuropathic pain
11/15/2006	EP1562907B1 Pyridine derivatives as cb2 receptor modulators
11/15/2006	EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1363648B1 Agastache rugosa extract having anti-inflammatory activity and anti-atherogenic activity
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1323711B1 Novel phenylalanine derivatives

1 ... 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 ... 1272